Results 231 to 240 of about 370,713 (268)
Some of the next articles are maybe not open access.

The impact of cerebrovascular disease

Diabetes, Obesity and Metabolism, 2000
Abstract Stroke may be affected by pathologic conditions such as atherosclerosis, vascular injury, coagulopathy, and increased platelet aggregability. Knowledge of the pathophysiology of stroke is critical in order to effectively prevent or treat this disabling state.
openaire   +2 more sources

AIDS and Cerebrovascular Disease

Stroke, 1996
Background Although neurological complications of human immunodeficiency virus (HIV) infection are common, the presence of cerebrovascular disease (CVD) has been seldom reported. The purpose of this report is to review available data on the association between stroke and acquired immunodeficiency syndrome (AIDS).
openaire   +2 more sources

Cerebrovascular Disease

Clinical Science, 1994
M, Fujishima, K, Fujii
openaire   +2 more sources

Cerebrovascular disease

Current Opinion in Neurology, 2012
Ralph L, Sacco, Tatjana, Rundek
openaire   +2 more sources

Cerebrovascular Disease

Circulation, 2000
P A, Wolf, J C, Grotta
openaire   +2 more sources

Fibrinogen and Cerebrovascular Disease

European Heart Journal, 1995
The importance of fibrinogen has been identified in two prospective observational studies. Reactive elevations in fibrinogen levels that occur within hours of a major stroke invalidate most cross-sectional case-control studies evaluating fibrinogen as a risk factor.
openaire   +2 more sources

Nanozyme‐Enabled Treatment of Cardio‐ and Cerebrovascular Diseases

Small, 2023
Yihong Zhang, Wanling Liu, Hui Wei
exaly  

Differences in the prevention and control of cardiovascular and cerebrovascular diseases

Pharmacological Research, 2021
Lida Du, Shoubao Wang, Linglei Kong
exaly  

Cerebrovascular disease and hyperlipoproteinemia

American Heart Journal, 1972
N R, Farid, J, Anderson
openaire   +2 more sources

Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer

Pharmaceuticals, 2022
Yoichi Morofuji   +2 more
exaly  

Home - About - Disclaimer - Privacy